Mesoblasts partner JCR Pharmacueticals announcement that it has filed its product GVHD FOR Adults and Children is a major step forward.It will be only a short period of time due to orphan drug status that this product is approved.They will also be launching phase 3 in lower back pain very shortly and will have a read out on Crohns desease by Christmas.These guys are professionals and are very close to having the first adult stem cell product approved for marketing..
Mesoblasts partner JCR Pharmacueticals announcement that it has...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |